Literature DB >> 4879562

Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems.

L A Wilson, J K Spitznagel.   

Abstract

The antibacterial action of antibody (normal and hyperimmune), complement, and lysozyme has been studied by correlating the ultrastructural and biochemical changes that they cause in smooth Escherichia coli. Both normal and hyperimmune antibody, in the absence of lysozyme, produced complement-dependent release, into the suspending medium, of 63 to 72% of the (32)P-labeled phospholipid and 74 to 85% of the small molecular bacterial constituents. Macromolecular nucleic acid labeled with (32)P was not released. By phase microscopy, these cells appeared as bacilli but their ultrastructure showed general swelling, with smoothing of the normally wrinkled outer cell wall layers. Cytoplasmic membranes were damaged and the internal cell structure was disorganized. Membranous spherules, apparently from the outermost putatively lipopolysaccharide cell layer, were released into the medium. When lysozyme was added to antibody and complement, (32)P-labeled macromolecular constituents were released from the cells. Damage to ultrastructure then included loss of cell wall rigidity, cell wall breakage, and some spheroplast formation. Characteristic fibrillar fragmentation was seen in cell wall mucopeptide layers. The relationships between antibody-complement dependent release of bacterial phospholipid, loss of selective cell permeability, and increase in sensitivity to lysozyme are discussed.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4879562      PMCID: PMC252452          DOI: 10.1128/jb.96.4.1339-1348.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  11 in total

1.  THE LOCATION OF THE MUCOPEPTIDE IN SECTIONS OF THE CELL WALL OF ESCHERICHIA COLI AND OTHER GRAM-NEGATIVE BACTERIA.

Authors:  R G MURRAY; P STEED; H E ELSON
Journal:  Can J Microbiol       Date:  1965-06       Impact factor: 2.419

2.  Quantitative studies on the bactericidal actions of serum and complement. I. A rapid photometric growth assay for bactericidal activity.

Authors:  L H MUSCHEL; H P TREFFERS
Journal:  J Immunol       Date:  1956-01       Impact factor: 5.422

3.  Phosphorus compounds in the cell. III. The incorporation of radioactive phosphorus into the ribonucleotide fraction of liver tissue.

Authors:  J N DAVIDSON; R M S SMELLIE
Journal:  Biochem J       Date:  1952-12       Impact factor: 3.857

4.  Response of Cell Walls of Escherichia coli to a Sudden Reduction of the Environmental Osmotic Pressure.

Authors:  M E Bayer
Journal:  J Bacteriol       Date:  1967-03       Impact factor: 3.490

5.  The chemistry and morphology of surface structures of lysine-limited Escherichia coli.

Authors:  E Work
Journal:  Folia Microbiol (Praha)       Date:  1967       Impact factor: 2.099

6.  A kinetic study of the bacteriolytic and bactericidal action of human serum.

Authors:  A A Glynn; C M Milne
Journal:  Immunology       Date:  1967-06       Impact factor: 7.397

7.  Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. I. Loss of label, death, and ultrastructural damage.

Authors:  J K Spitznagel; L A Wilson
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

8.  Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. II. Fate of macromolecular and lipid phosphorus of damaged cells.

Authors:  J K Spitznagel
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

9.  Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. 3. Isolation of a gammag normal antibody and characterization of other serum factors causing P32 loss.

Authors:  J K Spitznagel
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

10.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. 3. The membrane defects caused by complement lysis.

Authors:  W F Rosse; R Dourmashkin; J H Humphrey
Journal:  J Exp Med       Date:  1966-06-01       Impact factor: 14.307

View more
  19 in total

1.  Release of 14C label and complement killing of Escherichia coli.

Authors:  B M Wilson; A A Glynn
Journal:  Immunology       Date:  1975-03       Impact factor: 7.397

2.  Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.

Authors:  L M Madsen; M Inada; J Weiss
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Interaction of Gram-Negative Bacteria with the Lysosomal Fraction of Polymorphonuclear Leukocytes I. Role of Cell Wall Composition of Salmonella typhimurium.

Authors:  D Friedberg; M Shilo
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

4.  Effect of some R factors on the sensitivity of rough Enterobacteriaceae to human serum.

Authors:  A Fietta; E Romero; A G Siccardi
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

Review 5.  Structure and function of the cell envelope of gram-negative bacteria.

Authors:  J W Costerton; J M Ingram; K J Cheng
Journal:  Bacteriol Rev       Date:  1974-03

6.  Interaction of complement and polymyxin with gram-negative bacteria.

Authors:  H Pruul; B L Reynolds
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

7.  Interaction of ribosomes and the cell envelope of Escherichia coli mediated by lysozyme.

Authors:  D Patterson; M Weinstein; R Nixon; D Gillespie
Journal:  J Bacteriol       Date:  1970-02       Impact factor: 3.490

8.  Killing and lysis of gram-negative bacteria through the synergistic effect of hydrogen peroxide, ascorbic acid, and lysozyme.

Authors:  T E Miller
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

Review 9.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  Characteristics of complement-dependent release of phospholipid from Escherichia coli.

Authors:  L A Wilson; J K Spitznagel
Journal:  Infect Immun       Date:  1971-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.